N-Methyl-4-chloropyridine-2-carboxamide
N-Methyl-4-chloropyridine-2-carboxamide is an impurity of Sorafenib, which is a kinase inhibitor drug used for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.
Catalog Number | INT220000873 |
Alternative Name(s) | 4-Chloro-N-methylpicolinamide 4-Chloro-N-methylpyridine-2-carboxamide N-Methyl-4-chloropyridine-2-carboxamide 4-Chloro-N-methyl-2-pyridinecarboxamide |
Research Area | Intermediates |
Molecular Formula | C7H7ClN2O |
CAS# | 220000-87-3 |
SMILES | CNC(=O)C1=NC=CC(=C1)Cl |
Size | inquiry |
Supplier Page | https://www.protheragen-ing.com/n-methyl-4-chloropyridine-2-carboxamide-item-11144.html |